about
Putative adverse outcome pathways relevant to neurotoxicityInhibition of extension outgrowth in differentiating rat C6 glioma cells by chlorpyrifos and chlorpyrifos oxon: effects on microtubule proteinsNeurodegenerations induced by organophosphorous compounds.Role of transglutaminase 2 in PAC1 receptor mediated protection against hypoxia-induced cell death and neurite outgrowth in differentiating N2a neuroblastoma cells.Chlorpyrifos- and chlorpyrifos oxon-induced neurite retraction in pre-differentiated N2a cells is associated with transient hyperphosphorylation of neurofilament heavy chain and ERK 1/2.A1 adenosine receptor-induced phosphorylation and modulation of transglutaminase 2 activity in H9c2 cells: A role in cell survival.Sub-lethal concentrations of CdCl2 disrupt cell migration and cytoskeletal proteins in cultured mouse TM4 Sertoli cells.Phenyl Saligenin Phosphate Induced Caspase-3 and c-Jun N-Terminal Kinase Activation in Cardiomyocyte-Like Cells.Cardioprotective and cardiotoxic effects of quercetin and two of its in vivo metabolites on differentiated h9c2 cardiomyocytes.Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.Diazoxon disrupts the expression and distribution of βIII-tubulin and MAP 1B in differentiating N2a cells.Effects of sub-lethal neurite outgrowth inhibitory concentrations of chlorpyrifos oxon on cytoskeletal proteins and acetylcholinesterase in differentiating N2a cells.Alterations in the mitochondrial proteome of neuroblastoma cells in response to complex 1 inhibition.Neuroprotection from diazinon-induced toxicity in differentiating murine N2a neuroblastoma cells.Diazinon oxon affects the differentiation of mouse N2a neuroblastoma cells.The effects of diazinon and cypermethrin on the differentiation of neuronal and glial cell lines.Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: effects on MAP kinase (ERK 1/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activity.Effects of phenyl saligenin phosphate on phosphorylation of pig brain tubulin in vitro.Fipronil interferes with the differentiation of mouse N2a neuroblastoma cells.Effects of Chlorpyrifos and Chlorpyrifos-Methyl on the Outgrowth of Axon-Like Processes, Tubulin, and GAP-43 in N2a Cells.Effects of phenyl saligenin phosphate on cell viability and transglutaminase activity in N2a neuroblastoma and HepG2 hepatoma cell lines.The toxicity of chlorpyrifos towards differentiating mouse N2a neuroblastoma cells.Inhibition of neurite outgrowth in N2a cells by leptophos and carbaryl: effects on neurofilament heavy chain, GAP-43 and HSP-70.Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.Tricresyl phosphate inhibits the formation of axon-like processes and disrupts neurofilaments in cultured mouse N2a and rat PC12 cells.An extracellular transglutaminase is required for apple pollen tube growth.Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on differentiating mouse N2a neuroblastoma cells.The recovery of Arcobacter butzleri NCTC 12481 from various temperature treatments.Subcellular localization of iodinated thyroid tubulinSubcellular distribution and immunological detection of retrograde axonally transported proteins in acrylamide and diabetic neuropathies
P50
Q28392038-1868301A-5E9B-41B0-B514-809A49B043F9Q28576059-6ED6063A-3554-494F-9C8D-915BC387A9D4Q37992905-360089C3-3A46-4472-8E8D-BF87AB6716FAQ38722391-74B3112E-E6AC-459F-9CCD-FDE3C35B1DEBQ38752050-A35C56BA-A503-42B0-BDD6-F201D3D68DE4Q38783979-657BCB22-F55A-4590-A4A6-E1944AA37861Q38807087-A2D71EAC-0FC1-491E-97D6-1FAF58697ECAQ38828012-188B7D03-214B-4564-8BB9-B98B5B727ADAQ38958201-AD665F71-C2BF-4B22-956E-FA50A9599061Q38995669-1E4C711E-10D6-43DF-86D6-57B283E31021Q39034851-CA882F04-1BEA-4C8C-AD6B-163BFEBF8AC8Q39518307-E9316EF6-0371-43EE-AE18-0AE3B3B5D406Q39591876-A01DB41D-6C6A-4910-858B-7BFFD33B56ECQ39825942-1C84BEF1-F6CC-4E0F-B19F-D54782D4B46FQ39960379-12741CD4-153C-45E9-9099-343C68D32EDBQ40180842-67174B60-0E52-4FB5-B40E-DB6CF22CDCF2Q40311921-329D741B-0487-4C62-B24B-DA695C6A2367Q42729704-71A7A2BC-02C7-46B5-BB78-F5D61A94345DQ42776290-1BD2848B-11E5-4B34-9A01-6C0D19B0AF57Q43215645-67E64310-A64D-4E6E-A835-81CB652927CFQ43279941-1D31BB84-1CEC-442E-8B97-F360C06F1D87Q43744478-4D6FF115-659A-488E-8B1F-ABF13D7DD25BQ44284838-BBC694CC-16DE-44DE-92ED-49DCE09280F1Q47292576-CC9BC1FE-6F4F-4701-A1C4-FE3B7C0BE869Q50524871-E555FF79-A12F-40D4-80ED-C0A838E7BCA3Q50554531-895B0CA3-9B0B-4ABE-8ADD-51CCCF3EFAB6Q52077458-F2BEED43-5DD3-42CB-A23F-A17B6B3C226EQ53987147-7E6E806E-BEED-4FAD-8CCF-047AD8F75ABEQ60559992-D2B66E60-130A-4801-8C9B-01F690CFD791Q71610056-BA9E27B6-4298-404A-945D-1177D04C5C46
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alan J Hargreaves
@ast
Alan J Hargreaves
@en
Alan J Hargreaves
@es
Alan J Hargreaves
@nl
type
label
Alan J Hargreaves
@ast
Alan J Hargreaves
@en
Alan J Hargreaves
@es
Alan J Hargreaves
@nl
prefLabel
Alan J Hargreaves
@ast
Alan J Hargreaves
@en
Alan J Hargreaves
@es
Alan J Hargreaves
@nl
P106
P1153
7003896765
7005676929
P21
P31
P496
0000-0001-9754-5477